Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Pulse Biosciences, Inc. (PLSE)

2.97   -0.11 (-3.57%) 03-22 15:00
Open: 3.13 Pre. Close: 3.08
High: 3.13 Low: 2.95
Volume: 17,435 Market Cap: 115(M)

Technical analysis

as of: 2023-03-22 2:50:14 PM
Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 4.08     One year: 4.77
Support: Support1: 2.81    Support2: 2.39
Resistance: Resistance1: 3.5    Resistance2: 4.08
Pivot: 3.04
Moving Average: MA(5): 3.01     MA(20): 2.93
MA(100): 2.68     MA(250): 2.35
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 47     %D(3): 49.9
RSI: RSI(14): 48.2
52-week: High: 5.46  Low: 1.17
Average Vol(K): 3-Month: 53 (K)  10-Days: 31 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ PLSE ] has closed above bottom band by 38.8%. Bollinger Bands are 3.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.13 - 3.15 3.15 - 3.16
Low: 2.95 - 2.97 2.97 - 2.99
Close: 3.05 - 3.08 3.08 - 3.11

Company Description

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

Headline News

Tue, 21 Mar 2023
Semler Scientific's Q4 Earnings Report Exceeds Expectations - Best Stocks

Wed, 08 Mar 2023
Pulse Biosciences (NASDAQ:PLSE) Has Debt But No Earnings; Should You Worry? - Simply Wall St

Tue, 07 Mar 2023
How Does Pulse Biosciences Inc (PLSE) Stock Rank on Wall Street Tuesday? - InvestorsObserver

Thu, 02 Mar 2023
Pulse Biosciences Schedules Fourth Quarter & Full Year 2022 ... - WV News

Thu, 02 Feb 2023
Pulse Biosciences Announces Its Novel Nanosecond Pulsed Field ... - Business Wire

Tue, 06 Dec 2022
Pulse Biosciences CFO resigns (NASDAQ:PLSE) - Seeking Alpha

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Instruments & Supplies
Shares Out. 0 (M)
Shares Float 37 (M)
% Held by Insiders 1.562e+007 (%)
% Held by Institutions 56.9 (%)
Shares Short 2,140 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -6.341e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -4
Return on Assets (ttm) 167.5
Return on Equity (ttm) -52.3
Qtrly Rev. Growth 1.55e+006
Gross Profit (p.s.) 0
Sales Per Share -217.68
EBITDA (p.s.) -495496
Qtrly Earnings Growth -2.2
Operating Cash Flow 0 (M)
Levered Free Cash Flow -52 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.02
Price to Cash Flow 3.64

Stock Dividends

Dividend 0
Forward Dividend 2.19e+006
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.